With a 400% increase in overdose deaths involving psychostimulants in Massachusetts over the last two decades, this study could be a game-changer.
Substance Use Disorder
New provider principles lay out how to treat patients according to their unique, age-specific needs — and elevate national discussions on systemic changes.
Patients with dual diagnoses need comprehensive, integrated care if treatment is going to make a difference in both areas of need.
Clinicians who treat this population are in a unique position to advocate for more integrated partnerships between community entities and health centers.
Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for opioid use disorder.